Benitec Biopharma's total assets for Q2 2026 were AU$190.68M, an increase of 98.57% from the previous quarter. BNTC total liabilities were AU$3.32M for the fiscal quarter, a 36.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.